Hormone receptor-positive cancers are those that express receptors for estrogen (ER) and/or progesterone (PR). These receptors, when bound to their respective hormones, can stimulate cancer cell growth. Approximately 70% of breast cancers are hormone receptor-positive. Testing for these receptors is crucial for determining the most effective treatment plan.
